Trial intelligence / Profile preview

FUNIL-cRa regimen in advanced renal cell carcinoma

NCT00003585Phase 2Completed

Sponsor
The University of New Mexico
Start
Aug 1996
Primary completion
Aug 2001
Modality
Cytokines & Interferons, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of fluorouracil, interferon alfa-2b, aldesleukin, isotretinoin in renal cell carcinoma (RCC), sponsored by The University of New Mexico. Started Aug 1996; status: completed.

02

Drugs

fluorouracilinterferon alfa-2baldesleukinisotretinoin
03

Conditions

renal cell carcinoma (RCC)

Beyond the preview

Go deeper on NCT00003585.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00003585.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call